Exact Mass: 468.3121

Exact Mass Matches: 468.3121

Found 78 metabolites which its exact mass value is equals to given mass value 468.3121, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

(9E,12Z)-10-Nitrooctadeca-9,12-dienoylcarnitine

3-[(10-nitrooctadeca-9,12-dienoyl)oxy]-4-(trimethylazaniumyl)butanoate

C25H44N2O6 (468.3199)


(9E,12Z)-10-nitrooctadeca-9,12-dienoylcarnitine is an acylcarnitine. More specifically, it is an (9E,12Z)-10-nitrooctadeca-9,12-dienoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (9E,12Z)-10-nitrooctadeca-9,12-dienoylcarnitine is therefore classified as a long chain AC. As a long-chain acylcarnitine (9E,12Z)-10-nitrooctadeca-9,12-dienoylcarnitine is generally formed through esterification with long-chain fatty acids obtained from the diet. The main function of most long-chain acylcarnitines is to ensure long chain fatty acid transport into the mitochondria (PMID: 22804748). Altered levels of long-chain acylcarnitines can serve as useful markers for inherited disorders of long-chain fatty acid metabolism. Carnitine palmitoyltransferase I (CPT I, EC:2.3.1.21) is involved in the synthesis of long-chain acylcarnitines (more than C12) on the mitochondrial outer membrane. Elevated serum/plasma levels of long-chain acylcarnitines are not only markers for incomplete FA oxidation but also are indicators of altered carbohydrate and lipid metabolism. High serum concentrations of long-chain acylcarnitines in the postprandial or fed state are markers of insulin resistance and arise from insulins inability to inhibit CPT-1-dependent fatty acid metabolism in muscles and the heart (PMID: 19073774). Increased intracellular content of long-chain acylcarnitines is thought to serve as a feedback inhibition mechanism of insulin action (PMID: 23258903). In healthy subjects, increased concentrations of insulin effectively inhibits long-chain acylcarnitine production. Several studies have also found increased levels of circulating long-chain acylcarnitines in chronic heart failure patients (PMID: 26796394). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

maropitant

N-[(5-tert-butyl-2-methoxyphenyl)methyl]-2-(diphenylmethyl)-1-azabicyclo[2.2.2]octan-3-amine

C32H40N2O (468.314)


   

Nuttingin B

Nuttingin B

C27H40N4O3 (468.31)


   

Nuttingin A

Nuttingin A

C27H40N4O3 (468.31)


   
   

Simplexin B

Simplexin B

C26H44O7 (468.3087)


   

mitrarioside D

mitrarioside D

C26H44O7 (468.3087)


   

(6S,13S)-cleroda-3,14-diene-6,13-diol 6-O-beta-D-glucopyranoside|alpha-vinyl-1,2,3,4,4a,7,8,8a-octahydro-alpha,1,2,4a,5-pentamethyl-1-naphthalenepropanol 4-O-beta-glucopyranoside

(6S,13S)-cleroda-3,14-diene-6,13-diol 6-O-beta-D-glucopyranoside|alpha-vinyl-1,2,3,4,4a,7,8,8a-octahydro-alpha,1,2,4a,5-pentamethyl-1-naphthalenepropanol 4-O-beta-glucopyranoside

C26H44O7 (468.3087)


   

amphimedoside D

amphimedoside D

C25H44N2O6 (468.3199)


   

stemodin 13-O-beta-D-glucopyranoside|stemodinoside B

stemodin 13-O-beta-D-glucopyranoside|stemodinoside B

C26H44O7 (468.3087)


   

474893-07-7

474893-07-7

C26H44O7 (468.3087)


   

pachycladin A

pachycladin A

C26H44O7 (468.3087)


   

alpha-eudesmol-beta-D-glucopyranoside-6O-isovalerate

alpha-eudesmol-beta-D-glucopyranoside-6O-isovalerate

C26H44O7 (468.3087)


   

24-Methyl-26,27-bisnor-22-cholestene-3,4,6,8,15,16,25-heptol

24-Methyl-26,27-bisnor-22-cholestene-3,4,6,8,15,16,25-heptol

C26H44O7 (468.3087)


   

(4R,13S)-18-O-beta-D-glucopyranosyllabda-8(17),14-dien-13-ol|{(1R,4aR,5S,8aR)-decahydro-1,4a-dimethyl-6-methylide-5-[(3S)-3-hydroxy-3-methylpent-4-en-1-yl]naphthalen-1-yl}methyl beta-D-glucopyranoside

(4R,13S)-18-O-beta-D-glucopyranosyllabda-8(17),14-dien-13-ol|{(1R,4aR,5S,8aR)-decahydro-1,4a-dimethyl-6-methylide-5-[(3S)-3-hydroxy-3-methylpent-4-en-1-yl]naphthalen-1-yl}methyl beta-D-glucopyranoside

C26H44O7 (468.3087)


   

Malonganenone O

Malonganenone O

C27H40N4O3 (468.31)


   

Malonganenone Q

Malonganenone Q

C27H40N4O3 (468.31)


   
   

Euryspingiol B5|Euryspongiol B5

Euryspingiol B5|Euryspongiol B5

C26H44O7 (468.3087)


   

1alpha-hydroxy-ent-13-epi-manoyl oxide 1-O-beta-D-galactopyranoside|phaeoside

1alpha-hydroxy-ent-13-epi-manoyl oxide 1-O-beta-D-galactopyranoside|phaeoside

C26H44O7 (468.3087)


   

3beta,16alpha-dihydroxy-ent-kaurane-3-O-beta-D-glucopyranoside

3beta,16alpha-dihydroxy-ent-kaurane-3-O-beta-D-glucopyranoside

C26H44O7 (468.3087)


   

sagittarioside a

sagittarioside a

C26H44O7 (468.3087)


   

16alpha,19-dihydroxy-ent-kaurane 19-O-beta-D-glucopyranoside

16alpha,19-dihydroxy-ent-kaurane 19-O-beta-D-glucopyranoside

C26H44O7 (468.3087)


   

CID 73554066

(2R,3S,4R,5R,6R)-2-(hydroxymethyl)-6-[[(1R,4S,9S,10S,13R,14S)-14-hydroxy-5,5,9,14-tetramethyl-7-tetracyclo[11.2.1.01,10.04,9]hexadecanyl]oxy]oxane-3,4,5-triol

C26H44O7 (468.3087)


   

Lys Lys Pro Pro

(2S)-1-{[(2S)-1-[(2S)-6-amino-2-[(2S)-2,6-diaminohexanamido]hexanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidine-2-carboxylic acid

C22H40N6O5 (468.306)


   

Lys Pro Lys Pro

(2S)-1-[(2S)-6-amino-2-{[(2S)-1-[(2S)-2,6-diaminohexanoyl]pyrrolidin-2-yl]formamido}hexanoyl]pyrrolidine-2-carboxylic acid

C22H40N6O5 (468.306)


   

Lys Pro Pro Lys

(2S)-6-amino-2-{[(2S)-1-{[(2S)-1-[(2S)-2,6-diaminohexanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}hexanoic acid

C22H40N6O5 (468.306)


   

Pro Lys Lys Pro

(2S)-1-[(2S)-6-amino-2-[(2S)-6-amino-2-[(2S)-pyrrolidin-2-ylformamido]hexanamido]hexanoyl]pyrrolidine-2-carboxylic acid

C22H40N6O5 (468.306)


   

Pro Lys Pro Lys

(2S)-6-amino-2-{[(2S)-1-[(2S)-6-amino-2-[(2S)-pyrrolidin-2-ylformamido]hexanoyl]pyrrolidin-2-yl]formamido}hexanoic acid

C22H40N6O5 (468.306)


   

Pro Pro Lys Lys

(2S)-6-amino-2-[(2S)-6-amino-2-{[(2S)-1-{[(2S)-pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}hexanamido]hexanoic acid

C22H40N6O5 (468.306)


   

(7E)-(3S, 6RS)-6,19-epidioxy-24,24-difluoro-9,10-seco-5(10),7-cholestadiene-3,25-diol

(6RS)-6,19-epidioxy-24,24-difluoro-25-hydroxy-6,19-dihydrovitamin D3 / (6RS)-6,19-epidioxy-24,24-difluoro-25-hydroxy-6,19-dihydrocholecalciferol

C27H42F2O4 (468.3051)


   

(3?,5?,8?,9?,10?,16?)-16-Hydroxykauran-3-yl ?-D-glucopyranoside

(3?,5?,8?,9?,10?,16?)-16-Hydroxykauran-3-yl ?-D-glucopyranoside

C26H44O7 (468.3087)


   

(6RS)-6,19-epidioxy-24,24-difluoro-25-hydroxy-6,19-dihydrovitamin D3

(7E)-(3S, 6RS)-6,19-epidioxy-24,24-difluoro-9,10-seco-5(10),7-cholestadiene-3,25-diol

C27H42O4F2 (468.3051)


   

1,2-bis(ethenyl)benzene,1-(2-ethenylphenyl)-N,N-dimethylmethanamine,1-(2-ethenylphenyl)-N,N-dimethylmethanamine oxide

1,2-bis(ethenyl)benzene,1-(2-ethenylphenyl)-N,N-dimethylmethanamine,1-(2-ethenylphenyl)-N,N-dimethylmethanamine oxide

C32H40N2O (468.314)


   

Thiol-C9-PEG7

Thiol-C9-PEG7

C23H48O7S (468.3121)


   

Boc-NH-PEG7-NH2

Boc-NH-PEG7-NH2

C21H44N2O9 (468.3047)


   

maropitant

maropitant

C32H40N2O (468.314)


D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents Maropitant is a selective and orally active neurokinin (NK1) receptor antagonist. Maropitant acts by blocking the binding of substance P within the emetic center and the chemoreceptor trigger zone (CRTZ). Maropitant is highly effective in preventing vomiting[1][2].

   

(6RS)-6,19-epidioxy-24,24-difluoro-25-hydroxy-6,19-dihydrovitamin D3/(6RS)-6,19-epidioxy-24,24-difluoro-25-hydroxy-6,19-dihydrocholecalciferol

(6RS)-6,19-epidioxy-24,24-difluoro-25-hydroxy-6,19-dihydrovitamin D3/(6RS)-6,19-epidioxy-24,24-difluoro-25-hydroxy-6,19-dihydrocholecalciferol

C27H42F2O4 (468.3051)


   

[1-Myristoyl-glycerol-3-YL]phosphonylcholine

[1-Myristoyl-glycerol-3-YL]phosphonylcholine

C22H47NO7P+ (468.309)


   

(9E,12Z)-10-Nitrooctadeca-9,12-dienoylcarnitine

(9E,12Z)-10-Nitrooctadeca-9,12-dienoylcarnitine

C25H44N2O6 (468.3199)


   

(1S)-1-(cyclohexylmethyl)-1-(hydroxymethyl)-7-methoxy-9-methyl-N-propyl-2-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]carboxamide

(1S)-1-(cyclohexylmethyl)-1-(hydroxymethyl)-7-methoxy-9-methyl-N-propyl-2-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]carboxamide

C27H40N4O3 (468.31)


   

(1R)-1-(cyclohexylmethyl)-1-(hydroxymethyl)-7-methoxy-9-methyl-N-propyl-2-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]carboxamide

(1R)-1-(cyclohexylmethyl)-1-(hydroxymethyl)-7-methoxy-9-methyl-N-propyl-2-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]carboxamide

C27H40N4O3 (468.31)


   

[O-(2-O-Tetradecanoyl-L-glycero-3-phospho)choline]anion

[O-(2-O-Tetradecanoyl-L-glycero-3-phospho)choline]anion

C22H47NO7P+ (468.309)


   

2-[[(2R)-2-acetyloxy-3-dodecoxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(2R)-2-acetyloxy-3-dodecoxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C22H47NO7P+ (468.309)


   

L-gamma-Myristoyl-alpha-lysolecithin

L-gamma-Myristoyl-alpha-lysolecithin

C22H47NO7P+ (468.309)


   

2-[(2-Acetyloxy-3-dodecoxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[(2-Acetyloxy-3-dodecoxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C22H47NO7P+ (468.309)


   

2-[Hydroxy-(3-hydroxy-2-tetradecanoyloxypropoxy)phosphoryl]oxyethyl-trimethylazanium

2-[Hydroxy-(3-hydroxy-2-tetradecanoyloxypropoxy)phosphoryl]oxyethyl-trimethylazanium

C22H47NO7P+ (468.309)


   

2-[(2-Hexanoyloxy-3-octoxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[(2-Hexanoyloxy-3-octoxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C22H47NO7P+ (468.309)


   

2-[Hydroxy-(3-nonoxy-2-pentanoyloxypropoxy)phosphoryl]oxyethyl-trimethylazanium

2-[Hydroxy-(3-nonoxy-2-pentanoyloxypropoxy)phosphoryl]oxyethyl-trimethylazanium

C22H47NO7P+ (468.309)


   

2-[Hydroxy-(2-propanoyloxy-3-undecoxypropoxy)phosphoryl]oxyethyl-trimethylazanium

2-[Hydroxy-(2-propanoyloxy-3-undecoxypropoxy)phosphoryl]oxyethyl-trimethylazanium

C22H47NO7P+ (468.309)


   

2-[(2-Butanoyloxy-3-decoxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[(2-Butanoyloxy-3-decoxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C22H47NO7P+ (468.309)


   

ST 20:0;O2;Hex

ST 20:0;O2;Hex

C26H44O7 (468.3087)


   
   

9-(acetyloxy)-12,13-dihydroxy-6-isopropyl-3,9,13-trimethyl-15-oxatricyclo[6.6.1.0²,⁷]pentadecan-3-yl butanoate

9-(acetyloxy)-12,13-dihydroxy-6-isopropyl-3,9,13-trimethyl-15-oxatricyclo[6.6.1.0²,⁷]pentadecan-3-yl butanoate

C26H44O7 (468.3087)


   

(2r,3r,4s,5s,6r)-2-{[(1s,3r,4s,4ar,8ar)-4-[(3s)-3-hydroxy-3-methylpent-4-en-1-yl]-3,4,8,8a-tetramethyl-1,2,3,4a,5,6-hexahydronaphthalen-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1s,3r,4s,4ar,8ar)-4-[(3s)-3-hydroxy-3-methylpent-4-en-1-yl]-3,4,8,8a-tetramethyl-1,2,3,4a,5,6-hexahydronaphthalen-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C26H44O7 (468.3087)


   

1,3-dimethyl-7-(3,7,11,15-tetramethyl-13-oxohexadeca-2,6,10-trien-1-yl)purine-2,6-dione

1,3-dimethyl-7-(3,7,11,15-tetramethyl-13-oxohexadeca-2,6,10-trien-1-yl)purine-2,6-dione

C27H40N4O3 (468.31)


   

2-({3-ethenyl-3,4a,7,7,10a-pentamethyl-octahydro-1h-naphtho[2,1-b]pyran-10-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol

2-({3-ethenyl-3,4a,7,7,10a-pentamethyl-octahydro-1h-naphtho[2,1-b]pyran-10-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol

C26H44O7 (468.3087)


   

2,16-kauranediol; (ent-2α,16βoh)-form,2-o-beta-d-glucopyranoside

NA

C26H44O7 (468.3087)


{"Ingredient_id": "HBIN003533","Ingredient_name": "2,16-kauranediol; (ent-2\u03b1,16\u03b2oh)-form,2-o-beta-d-glucopyranoside","Alias": "NA","Ingredient_formula": "C26H44O7","Ingredient_Smile": "NA","Ingredient_weight": "468.62","OB_score": "NA","CAS_id": "34336-01-1","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "9036","PubChem_id": "NA","DrugBank_id": "NA"}

   

(2r,3r,4s,5s,6r)-2-{[(3r,4as,6as,7r,10ar,10bs)-3-ethenyl-3,4a,7,10a-tetramethyl-octahydro-1h-naphtho[2,1-b]pyran-7-yl]methoxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(3r,4as,6as,7r,10ar,10bs)-3-ethenyl-3,4a,7,10a-tetramethyl-octahydro-1h-naphtho[2,1-b]pyran-7-yl]methoxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C26H44O7 (468.3087)


   

1,3-dimethyl-7-(3,7,11,15-tetramethyl-13-oxohexadeca-2,6,11-trien-1-yl)purine-2,6-dione

1,3-dimethyl-7-(3,7,11,15-tetramethyl-13-oxohexadeca-2,6,11-trien-1-yl)purine-2,6-dione

C27H40N4O3 (468.31)


   

2-{[4-(3-hydroxy-3-methylpent-4-en-1-yl)-3,4,8,8a-tetramethyl-1,2,3,4a,5,6-hexahydronaphthalen-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

2-{[4-(3-hydroxy-3-methylpent-4-en-1-yl)-3,4,8,8a-tetramethyl-1,2,3,4a,5,6-hexahydronaphthalen-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C26H44O7 (468.3087)


   

1,3-dimethyl-7-[(2e,6e,10e)-3,7,11,15-tetramethyl-13-oxohexadeca-2,6,10-trien-1-yl]purine-2,6-dione

1,3-dimethyl-7-[(2e,6e,10e)-3,7,11,15-tetramethyl-13-oxohexadeca-2,6,10-trien-1-yl]purine-2,6-dione

C27H40N4O3 (468.31)


   

(9r,14as)-9-[(2r)-butan-2-yl]-5,7-dihydroxy-3-(7-hydroxyoctan-2-yl)-6-methyl-3h,4h,5h,6h,9h,12h,13h,14h,14ah-pyrrolo[2,1-c]1-oxa-4,7-diazacyclododecane-1,10-dione

(9r,14as)-9-[(2r)-butan-2-yl]-5,7-dihydroxy-3-(7-hydroxyoctan-2-yl)-6-methyl-3h,4h,5h,6h,9h,12h,13h,14h,14ah-pyrrolo[2,1-c]1-oxa-4,7-diazacyclododecane-1,10-dione

C25H44N2O6 (468.3199)


   

(1r,2s,3r,6r,7r,8r,9s,12s,13s)-3-(acetyloxy)-12,13-dihydroxy-6-isopropyl-3,9,13-trimethyl-15-oxatricyclo[6.6.1.0²,⁷]pentadecan-9-yl butanoate

(1r,2s,3r,6r,7r,8r,9s,12s,13s)-3-(acetyloxy)-12,13-dihydroxy-6-isopropyl-3,9,13-trimethyl-15-oxatricyclo[6.6.1.0²,⁷]pentadecan-9-yl butanoate

C26H44O7 (468.3087)


   

(2s,3r,4s,5s,6r)-2-{[(1r,2s,4s,7s,10s,12s,13s)-4-hydroxy-2,6,6,13-tetramethyltetracyclo[10.3.1.0¹,¹⁰.0²,⁷]hexadecan-13-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2s,3r,4s,5s,6r)-2-{[(1r,2s,4s,7s,10s,12s,13s)-4-hydroxy-2,6,6,13-tetramethyltetracyclo[10.3.1.0¹,¹⁰.0²,⁷]hexadecan-13-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C26H44O7 (468.3087)


   

(2r,3r,4s,5s,6r)-2-{[(1r,4ar,5s,8ar)-5-[(3s)-3-hydroxy-3-methylpent-4-en-1-yl]-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalen-1-yl]methoxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1r,4ar,5s,8ar)-5-[(3s)-3-hydroxy-3-methylpent-4-en-1-yl]-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalen-1-yl]methoxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C26H44O7 (468.3087)


   

2-({14-hydroxy-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-6-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol

2-({14-hydroxy-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-6-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol

C26H44O7 (468.3087)


   

1,3-dimethyl-7-[(2e,6e,11z)-3,7,11,15-tetramethyl-13-oxohexadeca-2,6,11-trien-1-yl]purine-2,6-dione

1,3-dimethyl-7-[(2e,6e,11z)-3,7,11,15-tetramethyl-13-oxohexadeca-2,6,11-trien-1-yl]purine-2,6-dione

C27H40N4O3 (468.31)


   

5,7-dihydroxy-3-(7-hydroxyoctan-2-yl)-6-methyl-9-(sec-butyl)-3h,4h,5h,6h,9h,12h,13h,14h,14ah-pyrrolo[2,1-c]1-oxa-4,7-diazacyclododecane-1,10-dione

5,7-dihydroxy-3-(7-hydroxyoctan-2-yl)-6-methyl-9-(sec-butyl)-3h,4h,5h,6h,9h,12h,13h,14h,14ah-pyrrolo[2,1-c]1-oxa-4,7-diazacyclododecane-1,10-dione

C25H44N2O6 (468.3199)


   

2-({3-ethenyl-3,4a,7,10a-tetramethyl-octahydro-1h-naphtho[2,1-b]pyran-7-yl}methoxy)-6-(hydroxymethyl)oxane-3,4,5-triol

2-({3-ethenyl-3,4a,7,10a-tetramethyl-octahydro-1h-naphtho[2,1-b]pyran-7-yl}methoxy)-6-(hydroxymethyl)oxane-3,4,5-triol

C26H44O7 (468.3087)


   

(3s,5s,6r,9r,14as)-9-[(2r)-butan-2-yl]-5,7-dihydroxy-3-[(2r,7s)-7-hydroxyoctan-2-yl]-6-methyl-3h,4h,5h,6h,9h,12h,13h,14h,14ah-pyrrolo[2,1-c]1-oxa-4,7-diazacyclododecane-1,10-dione

(3s,5s,6r,9r,14as)-9-[(2r)-butan-2-yl]-5,7-dihydroxy-3-[(2r,7s)-7-hydroxyoctan-2-yl]-6-methyl-3h,4h,5h,6h,9h,12h,13h,14h,14ah-pyrrolo[2,1-c]1-oxa-4,7-diazacyclododecane-1,10-dione

C25H44N2O6 (468.3199)


   

(2r,3r,4s,5r,6r)-2-{[(3r,4as,6ar,10s,10ar,10bs)-3-ethenyl-3,4a,7,7,10a-pentamethyl-octahydro-1h-naphtho[2,1-b]pyran-10-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5r,6r)-2-{[(3r,4as,6ar,10s,10ar,10bs)-3-ethenyl-3,4a,7,7,10a-pentamethyl-octahydro-1h-naphtho[2,1-b]pyran-10-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C26H44O7 (468.3087)


   

(2r,3r,4s,5s,6r)-2-{[(1s,4r,6s,9s,10r,13r,14r)-14-hydroxy-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-6-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1s,4r,6s,9s,10r,13r,14r)-14-hydroxy-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-6-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C26H44O7 (468.3087)


   

2-{[8-hydroxy-5-(5-hydroxy-3-methylpent-3-en-1-yl)-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalen-1-yl]methoxy}-6-methyloxane-3,4,5-triol

2-{[8-hydroxy-5-(5-hydroxy-3-methylpent-3-en-1-yl)-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalen-1-yl]methoxy}-6-methyloxane-3,4,5-triol

C26H44O7 (468.3087)


   

2-({4-hydroxy-2,6,6,13-tetramethyltetracyclo[10.3.1.0¹,¹⁰.0²,⁷]hexadecan-13-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol

2-({4-hydroxy-2,6,6,13-tetramethyltetracyclo[10.3.1.0¹,¹⁰.0²,⁷]hexadecan-13-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol

C26H44O7 (468.3087)


   

(1r,2s,3r,6r,7r,8r,9r,12s,13s)-3-(acetyloxy)-12,13-dihydroxy-6-isopropyl-3,9,13-trimethyl-15-oxatricyclo[6.6.1.0²,⁷]pentadecan-9-yl butanoate

(1r,2s,3r,6r,7r,8r,9r,12s,13s)-3-(acetyloxy)-12,13-dihydroxy-6-isopropyl-3,9,13-trimethyl-15-oxatricyclo[6.6.1.0²,⁷]pentadecan-9-yl butanoate

C26H44O7 (468.3087)


   

(2r,3r,4r,5r,6s)-2-{[(1r,4ar,5s,8s,8ar)-8-hydroxy-5-[(3e)-5-hydroxy-3-methylpent-3-en-1-yl]-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalen-1-yl]methoxy}-6-methyloxane-3,4,5-triol

(2r,3r,4r,5r,6s)-2-{[(1r,4ar,5s,8s,8ar)-8-hydroxy-5-[(3e)-5-hydroxy-3-methylpent-3-en-1-yl]-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalen-1-yl]methoxy}-6-methyloxane-3,4,5-triol

C26H44O7 (468.3087)


   

(2r,3r,4s,5s,6r)-2-{[(1s,4r,7r,9r,10r,13r,14r)-14-hydroxy-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1s,4r,7r,9r,10r,13r,14r)-14-hydroxy-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C26H44O7 (468.3087)